Close
Smartlab Europe
Inizio Ignite

Press Releases

Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

Castor, a leading provider of decentralized and hybrid clinical trial solutions, announced the official launch of its CRO Partnership program. Designed to support clinical research organizations (CROs), the program provides the technical capabilities, operational training and commercial resources required...

The leading supplier of injection vials Gerresheimer expands production in Wertheim

Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per...

Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share...

Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the trial is intended to support the label...

Sputnik V vaccine granted full permanent approval in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia’s Health Ministry. It had previously held temporary emergency use authorization (EUA) from...

New Zealand’s Medsafe Grants Provisional Approval for Novavax COVID-19 Vaccine

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,  announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV2373, Novavax' COVID-19 vaccine (adjuvanted), for active immunization to prevent coronavirus disease 2019...

DHL Supply Chain investing $400 million to grow its U.S. pharmaceutical and medical device distribution network

DHL Supply Chain, the global and North American contract logistics leader within Deutsche Post DHL Group, announced its Life Sciences and Healthcare (LSHC) sector is investing upwards of $400 million to expand its pharmaceutical and medical device distribution network...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »